Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Cameron J. Schweitzer"'
Autor:
Cameron J Schweitzer, John M Matthews, Christian J Madson, Meghan R Donnellan, Ronald L Cerny, Michael Belshan
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40537 (2012)
HIV-1 exploits numerous host cellular pathways for productive infection. To identify novel factors involved in HIV-1 replication, HIV-1 integrase and matrix protein complexes were captured at 4 hours post infection for proteomic analysis using an aff
Externí odkaz:
https://doaj.org/article/7dec69fa86314307bb71ea0bb2990a23
Autor:
Fang Zhang, Helen Cha, Qisheng Li, Cameron J. Schweitzer, Brianna Lowey, T. Jake Liang, Catherine Sodroski
Publikováno v:
Proceedings of the National Academy of Sciences. 113:7620-7625
Hepatitis C virus (HCV) enters the host cell through interactions with a cascade of cellular factors. Although significant progress has been made in understanding HCV entry, the precise mechanisms by which HCV exploits the receptor complex and host m
Publikováno v:
Journal of virology. 92(2)
Host cells harbor various intrinsic mechanisms to restrict viral infections as a first line of antiviral defense. Viruses have evolved various countermeasures against these antiviral mechanisms. Here we show that N-Myc downstream-regulated gene 1 ( N
Autor:
Pawel Ciborowski, Nicole A. Haverland, Teena Jagadish, Cameron J. Schweitzer, Michael Belshan
Publikováno v:
Journal of Proteome Research. 12:559-572
After entry into the cell, the early steps of the human immunodeficiency virus type 1 (HIV-1) replication cycle are mediated by two functionally distinct nucleoprotein complexes, the reverse transcription complex (RTC) and preintegration complex (PIC
Autor:
T. Jake Liang, Cameron J. Schweitzer
Publikováno v:
ACS infectious diseases. 1(9)
A new era has begun in the treatment of hepatitis C virus (HCV) infection with powerful yet expensive therapies. New treatments are emerging that target the entry step of HCV and could potentially block reinfection after liver transplant. These treat
Publikováno v:
Journal of Virological Methods. 159:178-184
This report describes the adaptation of the biotin ligase BirA—biotin acceptor sequence (BAS) labeling system to biotinylate specific human immunodeficiency virus 1 (HIV-1) proteins in vivo. Two HIV-1 clones were constructed, with the BAS introduce
Autor:
T. Jake Liang, Cameron J. Schweitzer
Publikováno v:
Current opinion in virology. 3(5)
Since the discovery of hepatitis C virus (HCV), treatment has proven difficult and the regimen of pegylated interferon-α and ribavirin is only effective for half of patients. Evidence suggests that host and viral genome variations play a role in eit
Autor:
Cameron J. Schweitzer, Shanshan He, Jingbo Xiao, T. Jake Liang, Virginia Chu, Nobuhiko Hiraga, Juan J. Marugan, Wei Zheng, Marc Ferrer, Billy Lin, Noel Southall, Xin Hu, Amy Wang, Kazuaki Chayama, Michio Imamura, Zongyi Hu, Qisheng Li
Publikováno v:
Science Translational Medicine
Hepatitis C virus (HCV) infection affects an estimated 185 million people worldwide, with chronic infection often leading to liver cirrhosis and hepatocellular carcinoma. Although HCV is curable, there is an unmet need for the development of effectiv
Autor:
Christian J. Madson, John M. Matthews, Meghan R. Donnellan, Cameron J. Schweitzer, Michael Belshan, Ronald L. Cerny
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 7, p e40537 (2012)
PLoS ONE, Vol 7, Iss 7, p e40537 (2012)
HIV-1 exploits numerous host cellular pathways for productive infection. To identify novel factors involved in HIV-1 replication, HIV-1 integrase and matrix protein complexes were captured at 4 hours post infection for proteomic analysis using an aff